Inaktiver Wert

Kurs Furiex Pharmaceuticals Inc

Aktien

Schlusskurs Nasdaq
- ^USD	-

02.07.14	Furiex Pharmaceuticals : Actavis Completes Acquisition of Furiex Pharmaceuticals
01.07.14	Furiex Pharmaceuticals : Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger
13.05.14	Furiex Pharmaceuticals : INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Furiex Pharmaceuticals, Inc. of Claims Against Board of Directors of Company In Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX
07.05.14	Furiex Pharmaceuticals : Reports First Quarter 2014 Financial Results
06.05.14	Actavis : Factbox - M&A frenzy transforming global pharma

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	Perf. 1 Jahr	Perf. 3 Jahre	Marktkap.($)
WUXI APPTEC CO., LTD.	-0.62%	+0.50%	+33.92%	+60.07%	64.38 Mrd.
ARGENX SE	+0.35%	+3.04%	+12.64%	+83.62%	56.16 Mrd.
LONZA GROUP AG	+0.53%	+2.55%	+13.90%	+104.77%	54.16 Mrd.
IQVIA HOLDINGS INC.	-2.81%	-3.95%	+22.72%	+48.57%	45.33 Mrd.
BEONE MEDICINES AG	-0.33%	-3.12%	+17.62%	+117.27%	42.25 Mrd.
REVOLUTION MEDICINES, INC.	+0.55%	+1.93%	+229.73%	+928.00%	40.78 Mrd.
GENMAB A/S	+3.27%	+47.40%	+110.44%	+94.92%	33.8 Mrd.
CELLTRION, INC.	+1.22%	-1.39%	+13.92%	+46.95%	32.25 Mrd.
WUXI BIOLOGICS (CAYMAN) INC.	-1.29%	-1.72%	+21.00%	-6.85%	23.57 Mrd.
Durchschnitt	+0.10%	+4.72%	+52.88%	+164.14%	43.63 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt	+0.02%	+3.64%	+49.57%	+162.47%